Efficacy of Clostridium butyricum M588 probiotics for the patients of constipation in schizophrenia: 4 weeks, a randomized, double blinded trial
- Conditions
- Schizophrenia
- Registration Number
- JPRN-UMIN000025409
- Lead Sponsor
- Fujita Health University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Not provided
1.Comatose patient 2.Patients under the strong influence of central nervous system depressants such as barbiturates, anesthetics 3.Patients under the influence of epinephrine 4.Patients under the influence of neurostimulatory substances such as stimulants and alcohol 5.Patients with a history of hypersensitivity to the ingredients of this drug 6.Patients who may be pregnant and pregnant 7.Patients with mental retardation 8.Patients with dementia combined 9.Patients with personality disorder complications 10.Patients diagnosed with irritable bowel syndrome by ROME III 11.Patients complicated of digestive organ diseases other than constipation 12.Patients already using live bacteria such as lactic acid bacteria and butyric acid bacteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method